ZEISS Ventures

What ZEISS Ventures does

ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, a privately held German optics and photonics conglomerate founded in 1846 and headquartered in Oberkochen, Germany, with ultimate ownership held by the Carl Zeiss Foundation (established 1888). Through its parent group, ZEISS operates across nine-plus business segments spanning Vision Care (prescription and plano sun lenses), Medical Technology (ophthalmology and microsurgery), Semiconductor Manufacturing Technology (lithography and metrology equipment, 50+ year track record), Industrial Quality Solutions (precision metrology), Research Microscopy Solutions (optical, electron/ion, and X-ray microscopes with up to one-million-times magnification), Photography and Cinematography, Hunting and Nature Observation, Spectroscopy and OEM Solutions, and Simulation/Planetariums. The group employs 40,000+ people globally and serves customers across North America, Europe, and Asia Pacific through a multi-channel model combining direct enterprise field sales, authorized dealer networks, eye care professional partnerships, B2B portals (MyZEISS), and e-commerce webshops.

Underlying technology centers on precision optics and photonics spanning optical imaging, laser systems, spectroscopy, electron/ion/X-ray microscopy, and digital pathology solutions. The group's digital layer includes arivis Cloud (AI-driven microscopy image analysis), the ZEISS Quality AI Platform (annotation-based training for image/video AI models), ZEISS Virtual Try-on, ZEISS Online Vision Screening, My Vision Profile, and the ZEISS Quality Library, with ZEISS ID providing single sign-on across customer, partner, and employee applications. ZEISS Ventures specifically deploys strategic early-stage capital into life sciences and deep tech companies aligned with the group's vertical focus, exemplified by its November 2025 co-led CHF 6.3 million seed investment in Arcoris Bio, a Swiss digital pathology company developing the MUSE multiplex biomarker detection platform.

ZEISS generates revenue predominantly through hardware sales of high-value optical systems across enterprise and consumer channels, supplemented by subscription-based digital platforms (arivis Cloud, Quality AI), licensing and royalties from OEM components and modules, and strategic investment returns through ZEISS Ventures. Pricing follows a multi-tier model: B2B enterprise custom quotes on multi-year contracts for industrial, medical, and semiconductor capital equipment; unit-based retail pricing for consumer vision care products distributed through eye care professionals; B2B wholesale/subscription pricing for plano sun lenses to sunglasses manufacturers (ZEISS Sunlens); and annual software subscriptions for cloud and AI platforms. Strategic alliances with Apple (ZEISS Optical Inserts for Apple Vision Pro) and vivo (smartphone camera optics) extend the ZEISS brand into XR and consumer electronics OEM channels, while ISO 9001/14001/45001/50001 certifications and a German Future Prize 2025 nomination for Medical Technology underscore the group's operational and innovation standing.

Name

ZEISS Ventures

Legal name

Carl Zeiss AG

Website

https://zeiss.com

Company type

Private

Founded year

1846

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

ZEISS Ventures is the corporate venture arm of ZEISS Group, a 175+ year German optics and photonics company with 40,000+ employees spanning medical technology, semiconductor manufacturing equipment, vision care, industrial metrology, and research microscopy, serving enterprise, healthcare, academic, and consumer customers globally.

Ownership category

akta.pro rank

Product category

Corporate Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investors, Nec (6799)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

Keywords

• Venture capital investments
• Strategic corporate investing
• Deep tech funding
• Life sciences investments
• Photonics technology ventures

Headquarters

HQ city

Oberkochen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Vision Care Products: ZEISS designs, develops, and manufactures eyeglass lenses, sun lenses, and eye examination equipment for eye care professionals and consumers. Revenue generated from prescription lenses, plano sun lenses, and vision care technology solutions.
2. Medical Technology: Products and solutions for ophthalmology and microsurgery including surgical microscopes, diagnostic equipment, and refractive laser systems. Revenue from medical device sales and service contracts.
3. Semiconductor Manufacturing Technology: Semiconductor manufacturing equipment and solutions enabling chip manufacturers. ZEISS has been providing semiconductor manufacturing equipment for over 50 years as a driver of global digitalization.
4. Industrial Quality Solutions: Measurement technology and metrology solutions for industries requiring precision, quality, and efficiency. Includes systems, software, and industrial metrology shop products.
5. Research Microscopy Solutions: Optical, electron/ion and X-ray microscopes for visualization of micro- and nanostructures in research applications.
6. Photography and Cinematography Lenses: ZEISS lenses for photography and major movie productions, including cinema lenses and professional photography equipment.
7. Digital Solutions and Software: Digital and software solutions including health solutions, manufacturing solutions, cloud platforms like arivis Cloud, and AI-powered analytics platforms.
8. OEM Components and Modules: Development, construction and manufacturing of precise optical components, modules and systems for OEM customers, including spectrometer solutions.
9. ZEISS Ventures Investment Returns: ZEISS Ventures operates as the corporate venture capital arm making strategic investments in early-stage companies like Arcoris Bio, generating returns through equity appreciation and strategic partnerships.

Pricing tiers

Go-to-market motion3 records

Distribution channels7 records

Marketing channels8 records

Core offering

ZEISS Ventures is the corporate venture capital arm of ZEISS Group, making strategic equity investments in early-stage companies in life sciences, diagnostics, and deep tech sectors aligned with ZEISS's optical and photonics expertise. In November 2025, ZEISS Ventures co-led a CHF 6.3 million seed funding round for Arcoris Bio alongside Ventura Ace, with participation from Zürcher Kantonalbank, to support development of the MUSE biomarker detection platform for digital pathology.

Product overview

ZEISS is a diversified technology company with a broad portfolio spanning photonics and optical technologies. The company operates as a multi-segment enterprise organized into distinct divisions including Vision Care (eyeglass lenses, eye care), Medical Technology (surgical and diagnostic equipment), Semiconductor Manufacturing Technology (chip-making equipment), Industrial Quality Solutions (metrology and inspection), Research Microscopy Solutions (electron/optical microscopes), Photography/Cinematography (camera lenses), Hunting/Nature Observation (optical devices), Simulation & Planetariums (projectors and dome systems), Spectroscopy (spectrometers), and OEM Solutions (custom components). The company also maintains significant digital capabilities through its Digital Innovation division offering Health Solutions and Manufacturing Solutions. Key digital platforms include arivis Cloud for AI-driven microscopy analysis, ZEISS Quality AI for training image-based AI models, ZEISS Online Vision Screening and My Vision Profile for consumer eye care, and various customer portals including MyZEISS and MyZEISS Vision. The company also offers identity management through ZEISS ID, learning platforms, quality tech guides, and digital asset management through the ZEISS Quality Library.

Differentiator

Problem solved

Functional benefit

Brands

• ZEISS Medical Technology: Products and solutions for ophthalmology and microsurgery
• ZEISS Research Microscopy Solutions
• ZEISS Semiconductor Manufacturing Technology
• ZEISS Industrial Quality Solutions
• ZEISS Vision Care
• ZEISS Sunlens
• ZEISS Photography
• ZEISS Cinematography
• ZEISS Extended Reality
• arivis Cloud

Products and services

• ZEISS Ventures Seed Investment Program Strategic seed-stage venture capital investments in early-stage companies developing technologies aligned with ZEISS's optical and photonics expertise, particularly in life sciences and diagnostics.
• Co-investment Partnership Program Joint venture capital investments with other institutional investors and corporate venture funds, enabling larger deal participation and shared due diligence.

Quantifiable outcome

• ZEISS Medical Technology nominated for German Future Prize 2025 for innovation in medical robotics and surgical technology.
• +2 more outcomes

Named customers10 records

Segments7 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• ApplecoreStrategic or Co-development Partner · 1 January 2024ZEISS partnered with Apple to develop ZEISS Optical Inserts for Apple Vision Pro, providing prescription lens customization for users with vision correction needs. The partnership involves Carl Zeiss Vision Inc. and Apple cooperating as joint controllers for data protection compliance.
• PUYI OPTICALminorStrategic or Co-development Partner · 1 January 2024PUYI OPTICAL, a luxury eyewear retailer, partnered with ZEISS on charity programs including eye check-ups for rural primary school students in Hunan province, China. PUYI operates ZEISS Vision Centers in Hong Kong.
• RWTH Aachen University and Ernst Ruska-CentreminorStrategic or Co-development Partner · 1 January 2022Prof. Joachim Mayer from RWTH Aachen University and Ernst Ruska-Centre for Microscopy and Spectroscopy collaborates with ZEISS on electron microscopy research and development, exploring materials science applications including neuromorphic computing materials.
• vivocoreStrategic or Co-development Partner · 1 January 2020ZEISS and vivo formed a strategic partnership for mobile imaging technology, with ZEISS providing optical expertise and camera technology for vivo smartphones. Spark Ni, Senior Vice President & CMO at vivo, has publicly discussed the collaboration in ZEISS Beyond Talks interviews.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat6 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/zeiss_group
• YouTubeyoutube.com/user/ZEISSGroup
• Facebookfacebook.com/zeissgroup
• LinkedInlinkedin.com/company/zeiss
• Instagraminstagram.com/zeissgroup

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZEISS Ventures